Brooklyn Investment Group’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$558K Buy
+8,879
New +$618K 0.02% 951
2025
Q4
Sell
-4,238
Closed -$366K 1516
2025
Q3
$366K Buy
4,238
+101
+2% +$7.99K 0.05% 360
2025
Q2
$361K Buy
4,137
+2,140
+107% +$168K 0.05% 376
2025
Q1
$136K Buy
1,997
+44
+2% +$3.59K 0.03% 437
2024
Q4
$152K Sell
1,953
-85
-4% -$6.29K 0.05% 284
2024
Q3
$137K Sell
2,038
-228
-10% -$18.7K 0.05% 298
2024
Q2
$313K Hold
2,266
0.13% 156
2024
Q1
$313K Buy
2,266
+56
+3% +$7.04K 0.13% 156
2023
Q4
$274K Buy
+2,210
New +$226K 0.13% 170

Other funds holding DXCM

Brooklyn Investment Group's DXCM Position: Q1 2026 in Review

Brooklyn Investment Group opened a new position in DexCom (DXCM) in Q1 2026: 8,879 shares worth $558K. The stake represents 0.02% of the portfolio and ranks #951 among its holdings. This is a return to the name: Brooklyn Investment Group previously reported a position in DXCM as recently as Q3 2025.

Brooklyn Investment Group first reported a position in DXCM in Q4 2023 and has held it in 9 quarters since. 960 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Brooklyn Investment Group held 8,879 shares of DexCom worth $558K as of Q1 2026.
  • DexCom was a new Brooklyn Investment Group position in Q1 2026.
  • DexCom made up 0.02% of Brooklyn Investment Group's portfolio in Q1 2026, its #951 holding.
  • Brooklyn Investment Group first reported a position in DexCom in Q4 2023 and has held it in 9 quarters since.
  • 960 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.